Strides Shasun Shares Gain On US FDA Nod

Posted By:
Subscribe to GoodReturns
For Quick Alerts
For Daily Alerts

    Shares in Strides Shasun gained ground after the company received US FDA Nod. The company said said it received approval from the US Food and Drug Administration for cetirizine hydrochloride capsules, used to relieve allergy symptoms.

    Strides Shasun Shares Gain On US FDA Nod
    In a notice to the stock exchanges, Strides Shasun said, "It has received approval from the US FDA for cetirizine hydrochloride capsules, 10mg (liquid filled capsules OTC)".

    The company said the product will be manufactured at its facility in Bengaluru and is ready for launch. Quoting IRI data, Strides Shasun said the US market for cetirizine hydrochloride capsules is approximately USD 60 million, with only one other generic player. Shares of the company were trading 0.16 per cent higher at Rs 1,089 on BSE.

    Read more about: strides
    Story first published: Monday, July 24, 2017, 12:16 [IST]
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    Get Latest News alerts from Goodreturns

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more